ESR1 and breast carcinoma: More recently, the same group [23] has demonstrated in a set of 21 patients with estrogen receptor positive breast cancer that choline metabolism assessed by 11C-choline PET and proliferation determined by 18FLT-PET were correlated in ER-positive breast cancer, concluding that high 11C-choline uptake is a measure of cellular proliferation in this setting.